Categories

• About

  Want to know more about the organization, strategic plan, services, and fee schedule? Ask here.

  1
  Topics
  2
  Posts

  

  @NatBourre You can see the link to the community guidelines in the top right corner of the forum or it will be a link available on all pages of the updated PAAB website.

• Announcements

  Announcements regarding our community

  5
  Topics
  17
  Posts

  

  All new cases, interactive tools and live Q&A's.

  The next PAAB Training Session is approaching fast. Don't miss out on this opportunity to learn virtually along with over 300 of your peers.

  The December 2nd session will cover banner ads in a gated HCP space, with examples of various marketing benefit claims, when and how they can be supported and presenting relative claims in absolute terms.

  We've also updated the agenda to make the January session all about Digital Conferences. You won't want to miss this!

  Session breakdowns for the 6 sessions and registration can be found at https://www.paabtraining.com/

  
  We hope to see you there.

• Tours

  A place for patient and healthcare professional feedback.

  5
  Topics
  5
  Posts

  A

  Enter your comments here.

• PAAB Forum Tutorials

  Have questions about how to use the forum, set up your account, functionality etc.? Ask them here and we'll help you out.

  1
  Topics
  1
  Posts

  A

  Lets start with a quick registration video.

• Newsletters/Blogs

  Blog posts from individual members

  7
  Topics
  37
  Posts

  

  As we move into 2021 and towards the next AODA compliance deadline, some sponsors/clients may seek to add an accessibility disclaimer to their websites similar to privacy policy and legal. This can be submitted to PAAB as an FYI. Note that the addition of the disclaimer on pre-gate websites should not link back to the corporate site, similar to requirements for privacy policy and legal pre-gate.

• PAAB Code

  Do you have questions about particular sections of the PAAB code? Do you have insights on how sections of the code be improved? Do you want to share insights about how related standards are addressed in other jurisdictions? Post here.

  17
  Topics
  20
  Posts

  

  Good Morning @donna
  The proposed change did not go forward. Although these were intended as the beginning of an incremental process of change, following consultation it became clear that the industry felt that the guidance did not go far enough. We are therefore awaiting preliminary output from the ongoing Health Canada and CADTH collaboration on decision-grade RWE. An expert stakeholder committee will work through that output to determine which elements are applicable to drug advertising.

  As a courtesy, the document Guidance on Observational Studies continues to inform on acceptable uses of observational studies in drug advertising.

• Events & Training

  Have more questions about training? Let us know.

  0
  Topics
  0
  Posts
  No new posts.
• Resources

  Guidance on Code Application

  Guidance on Submission Procedures

  Guidance on DTCA / DTCI Regulations

  Newsletters

  PAAB Icons

  Activities

  External Resources

  PAAB Logo
  80
  Topics
  100
  Posts

  A

  Please find the most up to date version of our draft Guiding Principles for Digital Conferences here and leave questions below.

• PAAB Q&A

  Claims & Support/References for Claims

  Non-product branded APS, pre-NOC teasers

  NHP, OTC

  CME, educational material, Reprints, reports, textbooks, independently created content

  DTCA/I, consumer secondary audience

  Electronic Media

  FYI post-approval change/preclearance exemption/what requires review/PAAB scope

  Miscellaneous

  Disclosure requirements: PI & Safety Information, Federal schedule, study parameters, reference lists

  Giveaways, Incentives & GIfts, contests, coupons (maybe activities)

  International Conferences

  Linkage Issues

  Patient Info

  Press Releases, Financial Reports, Unsolicited Requests

  Sampling

  Submission Requirements/process & Timelines/eFiles

  Terms of Market Authorization

  Visuals/Layout
  770
  Topics
  845
  Posts

  

  Hey @valeries

  As there seem to be a lot of moving parts to this question, we will attempt to provide some broad guiding principles.

  See PAAB Q&A 169 for key suggestions. While it speaks to HCP quotes, it can be extrapolated to experts in their respective fields (yoga, stress management and goal setting).

  If the patient-focused app community is branded, all content accessed through it (including podcasts) would be subject to advertising regulations.
  To help reduce the number of post recording changes, we generally suggest having a pre-reviewed script. When this is not possible, we suggest review of talking points so that the speaker is generally guided in the right direction. Post recording, a full script should be submitted to PAAB. Any copy which does not meet the regulations, will be requested to be removed.

  A similar thought process can be applied to patient interviews. While it is acceptable to have them, they must meet the limitations of patient information. For example, they should not be promotional. Like in PAAB Q&A 169, we suggest having a pre-approved script, or if this is not possible, a list of reviewed questions. The final script will be required for review and approval.